Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124966842 | 12496684 | 2 | F | 2015 | 20160706 | 20160624 | 20160713 | EXP | US-ABBVIE-16K-163-1658588-00 | ABBVIE | 58.25 | YR | F | Y | 84.44000 | KG | 20160713 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124966842 | 12496684 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 124966842 | 12496684 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | UNKNOWN | 0 | TABLET | ||||||||
| 124966842 | 12496684 | 3 | C | PEPCID | FAMOTIDINE | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 4 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 5 | C | IRON | IRON | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 7 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 8 | C | NOVOLOG | INSULIN ASPART | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 9 | C | LEVEMIR | INSULIN DETEMIR | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 10 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 124966842 | 12496684 | 12 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124966842 | 12496684 | 1 | Crohn's disease |
| 124966842 | 12496684 | 2 | Product used for unknown indication |
| 124966842 | 12496684 | 3 | Product used for unknown indication |
| 124966842 | 12496684 | 4 | Type 2 diabetes mellitus |
| 124966842 | 12496684 | 5 | Anaemia |
| 124966842 | 12496684 | 6 | Product used for unknown indication |
| 124966842 | 12496684 | 7 | Product used for unknown indication |
| 124966842 | 12496684 | 8 | Type 2 diabetes mellitus |
| 124966842 | 12496684 | 9 | Type 2 diabetes mellitus |
| 124966842 | 12496684 | 10 | Heart rate |
| 124966842 | 12496684 | 11 | Prophylaxis |
| 124966842 | 12496684 | 12 | Renal disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124966842 | 12496684 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124966842 | 12496684 | Hypocalcaemia | |
| 124966842 | 12496684 | Hypokalaemia | |
| 124966842 | 12496684 | Hypomagnesaemia | |
| 124966842 | 12496684 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124966842 | 12496684 | 1 | 2015 | 0 | ||
| 124966842 | 12496684 | 2 | 2013 | 20160627 | 0 | |
| 124966842 | 12496684 | 3 | 201606 | 0 |